Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have been assigned an average rating of “Buy” from the ...

Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven weight ...

This cohort study found that key sociodemographic, health care, and clinical factors are associated with receipt of semaglutide, a ...

Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling ...

Lipidated analogues of glucagon-like peptide 1 (GLP-1 ... This work provides a systematic study of the solubility, structure, oligomerization, and long-term stability of five different lipidated ...

Glucagon-like peptide-1 (GLP-1 ... could revolutionize how these drugs are administered and potentially affect their accessibility and cost structure. The adoption of GLP-1 coverage among employers ...

Speaking to Francesca Rudkin and Louise Ayrey on their NZ Herald podcast, The Little Things, he said many of these medications belong to a group of drugs called glucagon-like peptide-1 (GLP-1 ...

Take glucagon-like peptide-1 receptor agonists ... DiMarchi and his colleagues changed the structure of insulin to make it work better around mealtime for insulin-dependent diabetics.

The State Health Plan’s board of trustees will meet on Feb. 7, and while premium increases will not be voted on, the structure of ... no longer cover the popular Glucagon-like peptide 1 (GLP ...

Losing weight on a GLP-1 medication can have emotional and physical effects. Some changes are easier to handle than others, but users say the benefits are worth the effort.